China’s Fosun-owned Gland Pharma gets nod for proposed $814m IPO

China’s Fosun-owned Gland Pharma gets nod for proposed $814m IPO

Ravindra Sonavane

22 October, 2020

Printed by Unregistered user on Mon, 28 Jul 2025 12:20:00 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China's Fosun mulls $500m Indian IPO of Gland Pharma

China Fosun to buy 74% stake in Gland Pharma for $1.1b in revised deal

Read more from India

Venture Capital

India Digest: EatClub, Namo Realtech raise funding

Venture Capital

India’s Yali Capital closes $104m maiden deeptech fund